U.S. Electrical Stock News

NasdaqCM:VUZI
NasdaqCM:VUZIElectronic

Vuzix (VUZI) Q1 Loss Highlights Ongoing Profitability Strain And Tests Bullish Narratives

Vuzix (VUZI) has opened Q1 2026 with revenue of about US$1.4 million and a basic EPS loss of US$0.09, alongside a net loss excluding extra items of US$7.1 million, setting a cautious tone around profitability. Over the past year, the company has seen trailing twelve month revenue sit around US$6.1 million while the EPS loss on a trailing basis sits at US$0.39, anchoring expectations for what this latest quarter says about the trajectory of the business. With these numbers on the table, the...
NasdaqCM:PCT
NasdaqCM:PCTChemicals

PureCycle’s New Jersey Approval Links PureFive Resin To Revenue Potential

PureCycle Technologies (NasdaqCM:PCT) received temporary regulatory approval for its PureFive resin as postconsumer recycled content under New Jersey’s Recycled Content Law. This approval allows PureFive resin to be used in products aiming to comply with New Jersey’s recycled content requirements. The decision positions PureCycle as a potential supply partner for brands seeking to meet state recycled content mandates. PureCycle Technologies focuses on recycling polypropylene into higher...
NasdaqGM:AIRO
NasdaqGM:AIROAerospace & Defense

AIRO Group Holdings (AIRO) Is Down 13.2% After Wider Q1 Loss And New VTOL, ISR Launches – Has The Bull Case Changed?

Earlier this week, AIRO Group Holdings, Inc. reported first-quarter 2026 results showing sales of US$8.9 million and a wider net loss of US$15.45 million, while simultaneously unveiling two advanced unmanned platforms: a full-scale hybrid-electric VTOL aircraft and the RQ-70 Dainn long-range ISR system. These back-to-back product launches highlight AIRO’s push into heavier-lift, dual-use defense and logistics aircraft and AI-driven ISR systems, even as the company continues to evaluate...
NasdaqGS:ARWR
NasdaqGS:ARWRBiotechs

Arrowhead Licenses ARO PNPLA3 To Madrigal To Expand MASH Options

Arrowhead Pharmaceuticals (NasdaqGS:ARWR) has entered into an exclusive worldwide license agreement with Madrigal Pharmaceuticals for its ARO-PNPLA3 RNAi therapeutic. The deal covers development and commercialization of ARO-PNPLA3 for metabolic dysfunction-associated steatohepatitis, or MASH. The agreement includes potential milestone and royalty revenues for Arrowhead tied to Madrigal’s progress with the program. Arrowhead focuses on RNA interference therapies using its TRiM platform. MASH...
NYSE:SFL
NYSE:SFLOil and Gas

Is It Too Late To Consider SFL (SFL) After Its Strong Recent Share Price Gains

Wondering if SFL at around US$12.48 still offers value or if the easy gains are behind it? This article breaks down what the current price really means for you. SFL's share price has recently moved, with returns of 4.0% over 7 days, 14.6% over 30 days, 58.2% year to date, 57.0% over 1 year, 91.6% over 3 years and 124.9% over 5 years. This naturally raises questions about growth potential and changing risk perceptions. Recent news coverage around SFL has focused on its position in the energy...
NYSE:ORI
NYSE:ORIInsurance

Old Republic Fixed Income Deal And What It Means For Shareholders

Old Republic International (NYSE:ORI) has completed a substantial fixed-income offering, issuing new callable, senior, unsecured notes. The transaction adds fresh debt capital to the balance sheet, with terms structured around future call dates and interest payments. This funding move is designed to influence the company’s financial flexibility and long term funding mix. For investors tracking NYSE:ORI, the deal comes with the stock at $39.32 and a mixed return profile. Shares are up 11.4%...
NYSE:DAC
NYSE:DACShipping

Danaos Weighs Geopolitical Risks Against Fleet Growth And Valuation Potential

Danaos (NYSE:DAC) reports limited earnings impact from recent geopolitical disruptions, including the closure of the Strait of Hormuz, supported by long term charter coverage. The company is expanding its fleet in drybulk and LNG, adding Newcastlemax dry bulk carriers and 5,000 TEU containerships under new vessel orders. Contracted revenue backlog and additional energy sector investments point to a broader shift in how Danaos positions its shipping operations. For investors tracking...
NYSE:NEM
NYSE:NEMMetals and Mining

Newmont Weighs Fourmile Deal And Solitario Stake For Future Gold Growth

Newmont (NYSE:NEM) is exploring a potential partnership with Barrick on the Fourmile gold discovery, often described as one of the century’s largest finds. The two companies are reported to be in early discussions on a development agreement that could shape the long term future of the Fourmile asset. Separately, Newmont has increased its ownership stake in Solitario Resources Corp., expanding its exposure to additional mining assets. Newmont, trading at $109.06, has a mixed recent track...
NYSE:LOMA
NYSE:LOMABasic Materials

Loma Negra (LOMA) Reports Stronger Margins and Cash Flow: Is Its Profitability Story Shifting Gears?

Loma Negra Compañía Industrial Argentina Sociedad Anónima recently reported first-quarter 2026 results, with sales of ARS 218,739 million and net income of ARS 41,004 million, alongside higher earnings per share from continuing operations versus a year earlier. An interesting takeaway is that management credited a rebound in March cement activity and stronger margins for offsetting earlier industry softness and improving cash flow. Next, we’ll explore how this margin improvement and...
NYSE:WST
NYSE:WSTLife Sciences

West Pharmaceutical Cyberattack Tests Operational Resilience And Investor Risk Assumptions

West Pharmaceutical Services (NYSE:WST) reported a material cybersecurity incident involving data exfiltration and system encryption. The attack triggered a temporary suspension of global operations while the company worked to contain the breach. The full operational and financial impact remains uncertain as investigations and system restoration continue. West Pharmaceutical Services steps into this cyber event after a period of strong share price performance, with the stock up 40.3% over...
NasdaqGS:CSIQ
NasdaqGS:CSIQSemiconductor

Canadian Solar Resets Focus On U.S. Manufacturing And Margin Quality

Canadian Solar (NasdaqGS: CSIQ) has appointed Colin Parkin as CEO, with founder Shawn Qu shifting to Executive Chairman and CTO. The company is reorienting its business toward value driven growth and profitability instead of pure volume expansion. Canadian Solar has begun trial production at its new HJT solar cell factory in Indiana and expanded module capacity in Texas to build out its U.S. manufacturing base. For you as an investor, this marks a key moment for one of the largest solar and...
NYSEAM:REI
NYSEAM:REIOil and Gas

Ring Energy (REI) Is Down 15.5% After Discounted Equity Raise To Pay Down Debt - What's Changed

Earlier this week, Ring Energy, Inc. completed a US$60.00 million follow-on common stock offering at US$1.35 per share, issuing 44,444,445 shares primarily to repay borrowings under its senior secured revolving credit facility. This capital raise follows a first-quarter 2026 net loss of US$220.59 million and coincides with expanded responsibilities for CFO Sundip “Sonu” S. Johl as Principal Financial Officer, underscoring management’s focus on balance sheet repair and financial...
NYSEAM:LGCY
NYSEAM:LGCYConsumer Services

Legacy Education (LGCY) Earnings Growth Story Faces Slight Margin Decline Narrative Test

Legacy Education (LGCY) has put fresh numbers on the table for Q3 2026, with recent quarterly revenue figures around US$19.4 million in Q1 2026 and US$19.2 million in Q2 2026, alongside basic EPS of US$0.18 and US$0.16 respectively. This sets the backdrop for its latest update at a share price of US$11.92. Over the past year, the company has seen total revenue move from US$52.7 million to US$75.1 million and trailing 12 month EPS lift from US$0.62 to US$0.66, giving investors a clear sense of...
NasdaqGS:HCKT
NasdaqGS:HCKTIT

Is Hackett Group’s AI Pivot With IBM and Capital Returns Reframing the HCKT Investment Story?

In early May 2026, The Hackett Group reported first-quarter 2026 results showing lower sales and revenue than a year earlier but higher net income and earnings per share, reaffirmed its US$0.12 quarterly dividend, detailed recent share repurchases under its long-running buyback, and filed a US$3.47 million ESOP-related common stock shelf registration. Ahead of its AI-focused transition and new global collaboration with IBM, Hackett also issued second-quarter 2026 revenue guidance and...
NasdaqGM:WRD
NasdaqGM:WRDAuto Components

WeRide’s Global Robotaxi Expansion Meets Depressed Valuation Expectations

WeRide (NasdaqGM:WRD) reports record Q1 2026 revenue, supported by expanded robotaxi and ADAS operations. The company launches fully driverless robotaxi services in Dubai, Abu Dhabi, and Singapore, growing its presence outside China. WeRide introduces its Genesis simulation platform, designed to speed up training of autonomous driving AI models. WRD 3.0 receives top honors in China's urban driving competitions, highlighting progress in complex city environments. For investors tracking...
NYSE:AVEX
NYSE:AVEXAerospace & Defense

Is It Time To Reassess AEVEX (AVEX) After Recent Share Price Weakness?

With AEVEX trading at US$24.87, you might be wondering whether the current price really lines up with what the stock could be worth based on fundamentals. Over the short term, the share price has been under some pressure, with the stock down 0.8% over the last week and down 7.6% year to date. This may be changing how the market views its risk and reward profile. Recent coverage of AEVEX has focused less on short term headlines and more on giving investors a consistent view of the company...
NasdaqGM:CDNA
NasdaqGM:CDNABiotechs

CareDx Lawsuit Resolution Refocuses Attention On Valuation And Growth Prospects

CareDx (NasdaqGM:CDNA) disclosed that a long standing qui tam lawsuit has been dismissed. The company had previously announced that the Department of Justice closed a related investigation without findings of wrongdoing. Together, these outcomes remove a material legal overhang tied to historical compliance questions. CareDx focuses on transplant diagnostics and related services, an area where regulatory oversight and reimbursement policies are central to the business model. For investors...
NYSE:NSA
NYSE:NSASpecialized REITs

Is National Storage Affiliates (NSA) Fairly Priced After Its Strong Year To Date Rally?

Considering whether National Storage Affiliates Trust at around US$41.02 is offering fair value right now or if the price is out of line with the fundamentals. The stock is up 47.1% year to date and 20.2% over the past year, even though it has fallen 6.1% in the last week and 2.1% over the past month. Recent market attention has focused on how self storage REITs are positioned within real estate, as investors reassess income focused sectors and their sensitivity to interest rates. This...
NYSE:CRL
NYSE:CRLLife Sciences

Charles River Deepens Cell Therapy Role And Expands AI Pathology Platform

Charles River Laboratories International (NYSE:CRL) has entered into a partnership with MEDIPOST to support development and commercialization of cell therapies across Asia-Pacific and North America. The company is supplying biologics and GMP testing services to MEDIPOST’s global pipeline of regenerative medicine products. At the same time, Charles River introduced major upgrades to its digital pathology platform, adding AI-powered and fully digital workflows. The new digital pathology...
NasdaqGS:DLO
NasdaqGS:DLODiversified Financial

DLocal (DLO) Margin Compression In Q1 EPS Miss Strengthens Bearish Profitability Narrative

Payments platform DLocal (NasdaqGS:DLO) has reported Q1 2026 revenue of US$335.9 million and basic EPS of US$0.14, with trailing twelve month revenue at about US$1.2 billion and EPS of US$0.66 framing the broader earnings picture. Over the past year, the company has seen revenue lift from US$745.97 million to US$1.21 billion and EPS move from US$0.42 to US$0.66 on a trailing basis, alongside earnings growth of 28.7% and a trailing net margin of 15.8% versus 19.2% in the prior year. The latest...
NasdaqCM:PAYS
NasdaqCM:PAYSDiversified Financial

Assessing Paysign (PAYS) Valuation After Record Q1 Results And Patient Affordability Shift

Paysign (PAYS) is back in focus after reporting record first quarter 2026 results, with revenue of US$28.04 million and net income of US$5.44 million, while its patient affordability business became the largest contributor. See our latest analysis for Paysign. The share price has been volatile around these earnings, slipping 2.94% on the day and 9.65% over the past week. However, the 90 day share price return of 65.78% and 1 year total shareholder return of 55.89% still point to strong recent...
NasdaqGM:RUM
NasdaqGM:RUMInteractive Media and Services

Rumble (RUM) Q1 2026 Heavy EPS Loss Tests Bullish Margin Improvement Narrative

Rumble (RUM) just posted its Q1 2026 scorecard, with revenue of about US$25.5 million and a basic EPS loss of US$0.12, while the trailing twelve months show revenue of roughly US$102.4 million against a basic EPS loss of US$0.42. Over recent quarters, the company has seen revenue fluctuate in a tight band between roughly US$23.7 million and US$30.2 million, while quarterly basic EPS losses moved from around US$0.01 to US$1.15, highlighting ongoing pressure on profitability. For investors,...
NYSE:SQM
NYSE:SQMChemicals

SQM Weighs Higher Dividend With New Codelco Lithium Joint Venture

Sociedad Química y Minera de Chile (NYSE:SQM) has proposed raising its final dividend payout ratio from 30% to 50% of net income. The company has also finalized a lithium joint venture with Chilean state miner Codelco, focused on lithium operations. Sociedad Química y Minera de Chile, or SQM, is a Chile based chemicals and mining company with a major focus on lithium for battery production, along with other specialty fertilizers and industrial chemicals. The combination of a higher proposed...
NYSE:BAP
NYSE:BAPBanks

Credicorp (NYSE:BAP) Margins Improve To 33.5% Reinforcing Bullish Earnings Narratives

Credicorp (NYSE:BAP) has just posted another set of quarterly numbers that keep the focus on earnings power, with Q4 2025 revenue at S/5.4 billion and basic EPS of S/19.9 alongside net income of S/1.6 billion. Over the past few quarters, revenue has moved from S/4.6 billion in Q3 2024 to S/5.1 billion in Q4 2024 and then to S/5.4 billion in Q4 2025. Quarterly EPS shifted from S/14.0 to S/22.4 at the start of 2025 before landing at S/19.9 in the latest period, highlighting trailing earnings...